{"id":895,"date":"2024-01-22T13:24:40","date_gmt":"2024-02-01T13:27:48","guid":{"rendered":"https:\/\/devm.kyowakirininternational.com\/?page_id=895"},"modified":"2025-06-11T12:05:41","modified_gmt":"2025-06-11T11:05:41","slug":"onze-aandachtsgebieden","status":"publish","type":"page","link":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/","title":{"rendered":"Onze aandachtsgebieden"},"content":{"rendered":"\n[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; custom_margin=&#8221;25px||-30px||false|false&#8221; global_module=&#8221;692&#8243; saved_tabs=&#8221;all&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; _builder_version=&#8221;4.26.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#e5e5e5&#8243; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; custom_margin=&#8221;-55px||||false|false&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|desktop&#8221; custom_padding=&#8221;0px|0px|0px|0px|false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; admin_label=&#8221;Column&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;25px|||5px|false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text content_tablet=&#8221; <\/p>\n<p style=%22text-align: center;%22><a href=%22https:\/\/www.kyowakirinhub.com\/%22 data-et-target-link=%22_blank%22 rel=%22noopener%22><span style=%22color: #ff6600;%22>Healthcare Professionals Hub<\/span><\/a><\/p>\n<p> &#8221; content_phone=&#8221;<\/p>\n<p style=%22text-align: center;%22><a href=%22https:\/\/www.kyowakirinhub.com\/%22 data-et-target-link=%22_blank%22 rel=%22noopener%22><span style=%22color: #ff6600;%22>Healthcare Professionals Hub<\/span><\/a><\/p>\n<p>&#8221; content_last_edited=&#8221;on|phone&#8221; admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700|||||||&#8221; text_text_color=&#8221;#ea5504&#8243; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||||false|false&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;||||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;||||false|false&#8221; link_option_url_new_window=&#8221;on&#8221; text_text_color_tablet=&#8221;&#8221; text_text_color_phone=&#8221;&#8221; text_text_color_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<p style=\"text-align: center;\"><a href=\"https:\/\/www.kyowakirinhub.com\/nl-nl\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #ff6600;\">Hub voor zorgverleners <\/span><\/a><\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; admin_label=&#8221;Column&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; admin_label=&#8221;Column&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; background_color_phone=&#8221;RGBA(255,255,255,0)&#8221; background_last_edited=&#8221;on|phone&#8221; background_enable_color_phone=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700|||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#ea5504&#8243; width=&#8221;100%&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;||||false|false&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;||||false|false&#8221; custom_margin_last_edited=&#8221;on|desktop&#8221; custom_padding=&#8221;10px||||false|false&#8221; link_option_url=&#8221;https:\/\/kyowakirininternational.com\/global-reporting\/&#8221; link_option_url_new_window=&#8221;on&#8221; border_color_all=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<p style=\"text-align: center;\">Het melden van een bijwerking <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/Link-to-external-1.png\" width=\"26\" height=\"28\" alt=\"\" class=\"wp-image-615 alignnone size-full\" \/><\/p>\n<p style=\"text-align: center;\">[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; z_index=&#8221;500&#8243; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; min_height=&#8221;100px&#8221; height=&#8221;100px&#8221; overflow-x=&#8221;visible&#8221; overflow-y=&#8221;visible&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;|||25px|false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_menu menu_id=&#8221;37&#8243; active_link_color=&#8221;#ea5504&#8243; dropdown_menu_bg_color=&#8221;#5d6164&#8243; dropdown_menu_line_color=&#8221;#ff3300&#8243; dropdown_menu_text_color=&#8221;#000000&#8243; dropdown_menu_active_link_color=&#8221;#ff3300&#8243; mobile_menu_bg_color=&#8221;#b4c0c1&#8243; mobile_menu_text_color=&#8221;#000000&#8243; logo=&#8221;https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/KyowaKirin_BrandLogo_colorv2-PhotoRoom-1-1024&#215;216.png&#8221; logo_url=&#8221;https:\/\/kyowakirininternational.com\/nl-nl\/&#8221; logo_width=&#8221;100%&#8221; logo_max_width=&#8221;17%&#8221; show_search_icon=&#8221;on&#8221; search_icon_color=&#8221;#ea5504&#8243; menu_icon_color=&#8221;#ea5504&#8243; logo_max_width_tablet=&#8221;35%&#8221; logo_max_width_phone=&#8221;76%&#8221; logo_max_width_last_edited=&#8221;on|phone&#8221; show_search_icon_tablet=&#8221;on&#8221; show_search_icon_phone=&#8221;on&#8221; show_search_icon_last_edited=&#8221;on|phone&#8221; search_icon_color_tablet=&#8221;#ea5504&#8243; search_icon_color_phone=&#8221;#ea5504&#8243; search_icon_color_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; menu_font=&#8221;|600|||||||&#8221; menu_text_color=&#8221;#5d6164&#8243; menu_font_size=&#8221;17px&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; custom_css_free_form=&#8221;.et_pb_menu__icon.et_pb_menu__search-button {||padding: 2% 2% 2% 1%;||||}&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_menu][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;100%&#8221; custom_margin=&#8221;-25px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][lwp_divi_breadcrumbs home_text=&#8221;Startpagina&#8221; font_icon=&#8221;&#x35;||divi||400&#8243; link_color=&#8221;#5d6164&#8243; separator_color=&#8221;#e95505&#8243; current_text_color=&#8221;#e95505&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; module_text_align=&#8221;left&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; text_orientation=&#8221;left&#8221; animation_style=&#8221;fade&#8221; global_module=&#8221;1047&#8243; global_colors_info=&#8221;{}&#8221;][\/lwp_divi_breadcrumbs][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#5d6164&#8243; height=&#8221;50px&#8221; height_tablet=&#8221;100px&#8221; height_phone=&#8221;140px&#8221; height_last_edited=&#8221;on|phone&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-40px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_menu menu_id=&#8221;40&#8243; menu_style=&#8221;centered&#8221; active_link_color=&#8221;#ea5504&#8243; dropdown_menu_line_color=&#8221;#ea5504&#8243; dropdown_menu_active_link_color=&#8221;#ea5504&#8243; mobile_menu_bg_color=&#8221;#b4c0c1&#8243; mobile_menu_text_color=&#8221;#000000&#8243; menu_icon_color=&#8221;#ea5504&#8243; _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; menu_text_color=&#8221;#FFFFFF&#8221; menu_font_size=&#8221;15px&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_menu][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; next_background_color=&#8221;#FFFFFF&#8221; admin_label=&#8221;Section&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#e5e5e5&#8243; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_stops=&#8221;#e4560b 0%|rgba(228,86,11,0.38) 100%&#8221; background_color_gradient_overlays_image=&#8221;on&#8221; background_image=&#8221;https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/03\/SSP1584-1-crop-1.jpg&#8221; bottom_divider_style=&#8221;curve2&#8243; bottom_divider_height=&#8221;48px&#8221; bottom_divider_repeat=&#8221;1x&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|700|||||||&#8221; header_text_color=&#8221;#FFFFFF&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<h1 style=\"text-align: left;\">Onze aandachtsgebieden<\/h1>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<p><span>Als een wereldwijd gespecialiseerd farmaceutisch bedrijf gevestigd in Japan, zetten we ons in om medicijnen en behandelingen te leveren met leven veranderende waarde voor mensen die getroffen zijn door onder gediagnosticeerde en onder behandelde ziekten. Met ervaring in het brengen van producten &#8216;van pijplijn naar pati\u00ebnten&#8217;, gebruiken we onze expertise om de impact van onze medicijnen en technologie\u00ebn op meerdere ziektegebieden te maximaliseren.<\/span><\/p>\n<p>&nbsp;<\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial author=&#8221;Dr Nick Kronfeld&#8221; job_title=&#8221;Head of Medical Affairs&#8221; company_name=&#8221;Kyowa Kirin International (KKI)&#8221; portrait_url=&#8221;https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/04\/Dr-Nick-scaled-1.jpg&#8221; quote_icon_color=&#8221;#FFFFFF&#8221; quote_icon_background_color=&#8221;#ea5504&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; body_text_color=&#8221;#FFFFFF&#8221; author_text_color=&#8221;#FFFFFF&#8221; position_text_color=&#8221;#FFFFFF&#8221; company_text_color=&#8221;#FFFFFF&#8221; background_enable_color=&#8221;off&#8221; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_stops=&#8221;#e55000 0%|rgba(229,87,10,0.58) 100%&#8221; background_color_gradient_overlays_image=&#8221;on&#8221; animation_style=&#8221;slide&#8221; animation_delay=&#8221;200ms&#8221; hover_enabled=&#8221;0&#8243; border_color_all=&#8221;RGBA(255,255,255,0)&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<p><span>Wij zijn toegewijd aan het vinden van nieuwe en innovatieve oplossingen om enkele van de zeldzaamste ziekten ter wereld te behandelen. Wij streven ernaar om het leven van pati\u00ebnten beter te maken en hen te laten lachen.<\/span><\/p>[\/et_pb_testimonial][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; next_background_color=&#8221;#dbdbdb&#8221; admin_label=&#8221;Section&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; bottom_divider_style=&#8221;mountains2&#8243; bottom_divider_height=&#8221;29px&#8221; bottom_divider_repeat=&#8221;1x&#8221; bottom_divider_flip=&#8221;vertical&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_3_text_color=&#8221;#ea5504&#8243; link_option_url=&#8221;#ctcl&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<h3><strong>Cutaan T-cellymfoom (CTCL)<\/strong><\/h3>\n<p><span>Cutaan T-cellymfoom, of CTCL, is een zeldzame vorm van non-Hodgkin-lymfoom, een type bloedkanker dat ontstaat wanneer het lichaam te veel witte bloedcellen (met name T-cellen) aanmaakt.<\/span><\/p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_3_text_color=&#8221;#ea5504&#8243; link_option_url=&#8221;#xlh&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<h3><strong>X-gebonden hypofosfatemie (XLH)<\/strong><\/h3>\n<p><span>X-gebonden hypofosfatemie, of XLH, is een zeldzame, erfelijke musculoskeletale aandoening die wordt veroorzaakt door een tekort aan fosfaat.<\/span><\/p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_3_text_color=&#8221;#ea5504&#8243; link_option_url=&#8221;#tio&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<h3><strong>Tumor-ge\u00efnduceerde osteomalacie (TIO)<\/strong><\/h3>\n<p><span>Tumor-ge\u00efnduceerde osteomalacie, of TIO, is een zeldzame, verworven stoornis van het fosfaat- en vitamine D-metabolisme die wordt veroorzaakt door doorgaans kleine endocriene tumoren.<\/span><\/p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_3_text_color=&#8221;#ea5504&#8243; link_option_url=&#8221;#mld&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<h3><strong>Metachromatische leukodystrofie (MLD)<\/strong><\/h3>\n<p>Metachromatische leukodystrofie, of MLD, is een zeldzame en levensbedreigende erfelijke aandoening van het stofwisselingssysteem van het lichaam.<\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; module_id=&#8221;ctcl&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#dbdbdb&#8221; bottom_divider_style=&#8221;mountains2&#8243; bottom_divider_color=&#8221;#b7b7b7&#8243; bottom_divider_height=&#8221;24px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<h1 style=\"text-align: center;\"><span>Cutaan T-cellymfoom (CTCL)<\/span><\/h1>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/05\/Hematology-Oncology-300&#215;200-1.png&#8221; alt=&#8221;Haemato-Oncology&#8221; title_text=&#8221;Hematology-Oncology-300&#215;200&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_4_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<p><span>Cutaan T-cellymfoom (CTCL) is een zeldzame vorm van non-Hodgkinlymfoom, een type bloedkanker dat ontstaat wanneer het lichaam te veel witte bloedcellen (met name T-cellen) aanmaakt. T-cellen maken deel uit van uw immuunsysteem en helpen het lichaam om ziektes of infecties te bestrijden. Sommige T-cellen voeren hun immuunfunctie uit in de huid en in het geval van CTCL hopen kankerachtige T-cellen zich op in het huidorgaan en kunnen ze er vaak uitzien als een huiduitslag of verhoogde plaque. Het is belangrijk om te begrijpen dat CTCL een bloedkanker is, ook al tast het eerst de huid aan.<\/span><\/p>\n<h4><strong><\/strong><\/h4>\n<h4><strong><span>VERSCHILLENDE SOORTEN CTCL<\/span> \u00a0<\/strong><\/h4>\n<p><span>Er zijn verschillende soorten CTCL die er op de huid anders uit kunnen zien, verschillende delen van het lichaam kunnen aantasten en zich met verschillende snelheden kunnen ontwikkelen. De bekendste soorten worden mycosis fungoides en het syndroom van S\u00e9zary genoemd. Mycosis fungoides wordt over het algemeen beschouwd als een ziekte die langzaam verloopt. Het is de meest voorkomende vorm van CTCL en is goed voor ongeveer 60% van de gevallen. Het syndroom van S\u00e9zary is een agressievere vorm van CTCL, die verschilt van mycosis fungoides door de totale betrokkenheid van het huidorgaan (erythrodermie) en het grotere aantal kankerachtige T-cellen dat in het bloed wordt aangetroffen.<br \/><\/span>\u00a0<\/p>\n<h4><strong>WAT IS DE OORZAAK VAN CTCL?<\/strong><\/h4>\n<p><span>Deskundigen weten niet wat CTCL veroorzaakt. Wetenschappelijke studies hebben echter aangetoond dat het niet besmettelijk is (wat betekent dat je het niet van anderen kunt krijgen of zelf kunt doorgeven), en het is onwaarschijnlijk dat het genetisch is.<\/span><\/p>\n<h4><strong><\/strong><\/h4>\n<h4><strong>EEN CTCL-DIAGNOSE KRIJGEN<\/strong><\/h4>\n<p><span>De eerste stap in de CTCL-diagnose is een huidbiopsie; de diagnose is echter niet altijd eenvoudig, zelfs niet voor een specialist. <br \/>Gezien de zeldzaamheid van de aandoening en de moeilijkheid om deze te identificeren, is vaak input van clinici uit verschillende specialismen (bijv. dermatologie, hematologie en pathologie) vereist. <br \/>Omdat huidlaesies bij CTCL lijken op die bij meer voorkomende aandoeningen zoals eczeem en psoriasis, duurt het gemiddeld ongeveer 3 jaar voordat een definitieve CTCL-diagnose wordt gesteld; voor sommigen zal dit sneller zijn en voor anderen kan het zelfs langer duren.<\/span><\/p>\n<p><strong><\/strong><\/p>\n<h4><strong>LEVEN MET CTCL<\/strong><\/h4>\n<p><span>Leven met CTCL kan iemands emotionele welzijn be\u00efnvloeden vanwege de impact die de ziekte heeft op hoe ze eruit zien en zich voelen, en op hun dagelijks leven. Lees <a href=\"https:\/\/ctclanswers.com\/\" target=\"_blank\" rel=\"noopener\">hier<\/a> meer over leven met CTCL. Er zijn verschillende organisaties voor mensen met CTCL of andere zeldzame vormen van kanker die praktisch advies kunnen geven over het dagelijks leven en ondersteuning kunnen bieden bij het omgaan met hun gevoelens. Klik <a href=\"https:\/\/www.clfoundation.org\/\" target=\"_blank\" rel=\"noopener\">hier<\/a> om de Cutaneous Lymphoma Foundation te bezoeken, een pati\u00ebntenbelangenorganisatie die mensen met CTCL over de hele wereld ondersteunt.<\/span><\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; module_id=&#8221;xlh&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#dbdbdb&#8221; bottom_divider_style=&#8221;mountains2&#8243; bottom_divider_color=&#8221;#b7b7b7&#8243; bottom_divider_height=&#8221;26px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<h1 style=\"text-align: center;\"><span>X-gebonden hypofosfatemie (XLH)<\/span><\/h1>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/04\/Rare-metabolic-disorders-1.jpg&#8221; alt=&#8221;Rare Metabolic Diseases&#8221; title_text=&#8221;Chromosome X and Y&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_4_text_color=&#8221;#ea5504&#8243; custom_padding=&#8221;||0px|||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<p><span>X-gebonden hypofosfatemie, of XLH, is een zeldzame, erfelijke musculoskeletale aandoening die wordt veroorzaakt door een tekort aan fosfaat. Ons lichaam heeft gedurende ons hele leven fosfaat nodig om goed te groeien en zich te ontwikkelen. Fosfaat is nodig voor gezonde botten, tanden, bloed en spieren, en is betrokken bij het voorzien van ons lichaam van energie. Het grootste deel van het fosfaat uit onze voeding komt terecht in onze tanden en botten, waar het, samen met calcium, essentieel is voor levenslange botgezondheid. XLH is een levenslange aandoening die kinderen en volwassenen op verschillende manieren treft, met symptomen die van persoon tot persoon verschillen. Deze kunnen pseudofracturen, artrose, gewrichts- en botpijn en gebitsproblemen omvatten.<\/span><\/p>\n<h4><strong><\/strong><\/h4>\n<h4><strong>WAT IS DE OORZAAK VAN XLH?<\/strong><\/h4>\n<p><span>XLH is een genetische aandoening die ontstaat door een mutatie op een X-chromosoom. Deze mutatie zorgt voor een overmaat aan fibroblastgroeifactor 23 (FGF23), waardoor de nieren van een persoon te veel fosfaat in de urine laten. Deze &#8216;fosfaatverspilling&#8217; leidt tot een laag fosforgehalte in het bloed (ook bekend als hypofosfatemie). De meeste mensen met XLH erven de X-gebonden mutatie van een ouder. Echter, \u00e9\u00e9n op de drie mensen met XLH wordt geboren met de aandoening, ondanks dat er geen familiegeschiedenis is. Dit wordt &#8216;spontaan XLH&#8217; genoemd. Het is nog niet duidelijk waarom dit gebeurt.<\/span><\/p>\n<h4><strong><\/strong><\/h4>\n<h4><strong>DIAGNOSE VAN XLH<\/strong><\/h4>\n<p><span>LH wordt normaal gesproken op jonge leeftijd vastgesteld, rond de tijd dat we voor het eerst beginnen te lopen. Veelvoorkomende symptomen zijn een korte gestalte, O-benen of X-benen en polsen of knie\u00ebn die groter lijken dan normaal. Omdat het zo&#8217;n zeldzame aandoening is, kan XLH worden aangezien voor andere skeletaandoeningen, waaronder nutritionele rachitis, die wordt veroorzaakt door het niet eten van voldoende vitamine D-rijk voedsel.<\/span><\/p>\n<h4><strong><\/strong><\/h4>\n<h4><strong>LEVEN MET XLH<\/strong><\/h4>\n<p><span>XLH is een levenslange ziekte waarbij de symptomen en de ernst ervan in de loop van de tijd kunnen veranderen. Er zijn echter veel manieren waarop mensen met XLH een vol en actief leven kunnen leiden. En ondanks de zeldzaamheid van XLH zijn er veel gespecialiseerde zorgprofessionals en ondersteuningsgroepen die informatie, hulp en advies kunnen bieden. Klik <a href=\"https:\/\/xlhalliance.org\/\" target=\"_blank\" rel=\"noopener\">hier<\/a> om de International XLH Alliance te bezoeken, een internationale alliantie van pati\u00ebntengroepen voor mensen die getroffen zijn door XLH en gerelateerde aandoeningen.<\/span><\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; module_id=&#8221;tio&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#dbdbdb&#8221; bottom_divider_style=&#8221;mountains2&#8243; bottom_divider_color=&#8221;#b7b7b7&#8243; bottom_divider_height=&#8221;41px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<h1 style=\"text-align: center;\"><span>Tumor-ge\u00efnduceerde osteomalacie (TIO)<\/span><\/h1>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/04\/TIO_-1.png&#8221; title_text=&#8221;TIO_&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_4_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<p><span>Tumor-ge\u00efnduceerde osteomalacie, of TIO, is een zeldzame, verworven stoornis van het fosfaat- en vitamine D-metabolisme, veroorzaakt door doorgaans kleine endocriene tumoren. TIO wordt gekenmerkt door botpijn, vermoeidheid, spierzwakte, loopstoornissen en meerdere fracturen, wat kan leiden tot langdurige invaliditeit en langdurige morbiditeit.<\/span><\/p>\n<h4><strong>WAT IS DE OORZAAK VAN TIO?<\/strong><\/h4>\n<p><span>Bij TIO scheiden kleine endocriene tumoren fibroblastgroeifactor 23 (FGF23) uit, waardoor de nieren van een persoon te veel fosfaat in de urine laten passeren. Deze \u2018fosfaatverspilling\u2019 leidt tot lage fosfaatniveaus in het bloed (ook bekend als hypofosfatemie), wat onder andere invloed heeft op het botmetabolisme.<\/span><\/p>\n<h4><span>DIAGNOSE VAN TIO<\/span><\/h4>\n<p><span>De tekenen en symptomen van TIO zijn niet specifiek voor deze aandoening en bijgevolg kan &gt;95% van de gevallen verkeerd worden gediagnosticeerd en onjuist worden behandeld. Mensen met TIO kunnen vaak meerdere jaren wachten op een nauwkeurige diagnose.<\/span><\/p>\n<p>&nbsp;<\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; module_id=&#8221;mld&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#dbdbdb&#8221; bottom_divider_style=&#8221;slant2&#8243; bottom_divider_color=&#8221;#b7b7b7&#8243; bottom_divider_height=&#8221;30px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<h1 style=\"text-align: center;\"><span>Metachromatische leukodystrofie (MLD)<\/span><\/h1>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/04\/Gene-therapy-1.jpg&#8221; alt=&#8221;Gene Therapy&#8221; title_text=&#8221;Genetic mutation, conceptual illustration&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_4_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<p><span>Metachromatische leukodystrofie (MLD) is een zeldzame en levensbedreigende erfelijke aandoening van het stofwisselingssysteem van het lichaam.<\/span><\/p>\n<p><i><span data-contrast=\"none\"><\/span><\/i><\/p>\n<h4><strong>WAT IS DE OORZAAK VAN MLD?<\/strong><\/h4>\n<p><span>MLD wordt veroorzaakt door een mutatie in het ARSA-gen dat resulteert in de ophoping van vetten, sulfatiden genaamd, in de hersenen en andere delen van het lichaam, waaronder de lever, de galblaas en de nieren. Na verloop van tijd raakt het zenuwstelsel beschadigd en ervaren kinderen met MLD neurologische problemen zoals motorische, gedragsmatige en cognitieve regressie, ernstige spasticiteit en aanvallen, en vinden het steeds moeilijker om te bewegen, praten, slikken, eten en zien.<\/span><\/p>\n<p><i><span data-contrast=\"none\"><\/span><\/i><\/p>\n<h4><strong>DE LAST VAN MLD<\/strong><\/h4>\n<p><span>MLD komt naar schatting voor bij ongeveer \u00e9\u00e9n op de 100.000 levendgeborenen. Naar schatting sterft 50% van de kinderen met de meest agressieve vorm van MLD binnen vijf jaar na het begin van de ziekte als ze niet worden behandeld.<\/span><\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.26.0&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|700|||||||&#8221; header_text_color=&#8221;#ea5504&#8243; background_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<h1 style=\"text-align: center;\">Sources<\/h1>\n<p>\u200b<\/p>\n<ul>\n<li>Macmillan Cancer Support. Cutaneous T-cell lymphoma (CTCL). Available at: <a href=\"https:\/\/jpn01.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.macmillan.org.uk%2Fcancer-information-and-support%2Flymphoma%2Fnon-hodgkin%2Ftypes%2Fcutaneous-t-cell&amp;data=05%7C02%7CChris.Howden%40kyowakirin.com%7C4f8d0ac64ffe49b05a3e08dc8621f826%7C34db9a5d91ba486ebb82d37d2ee1d84c%7C0%7C0%7C638532727790067148%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=v7YiVdzosfACMDV3I0WZ5eMHrnxpVqD%2F98c7ELE4lME%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\">https:\/\/www.macmillan.org.uk\/cancer-information-and-support\/lymphoma\/non-hodgkin\/types\/cutaneous-t-cell<\/a> Accessed July 2024.<\/li>\n<li>Lymphoma Action. 2022. Skin (cutaneous) T-cell lymphoma. Available at: <a href=\"https:\/\/jpn01.safelinks.protection.outlook.com\/?url=https%3A%2F%2Flymphoma-action.org.uk%2Ftypes-lymphoma-skin-lymphoma%2Fskin-cutaneous-t-cell-lymphoma%23diagnosis&amp;data=05%7C02%7CChris.Howden%40kyowakirin.com%7C4f8d0ac64ffe49b05a3e08dc8621f826%7C34db9a5d91ba486ebb82d37d2ee1d84c%7C0%7C0%7C638532727790077450%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=y0xGv5OvT6fdTgWDVBVjUGD%2FOry2i2IvxYUSK0YkzK4%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\">https:\/\/lymphoma-action.org.uk\/types-lymphoma-skin-lymphoma\/skin-cutaneous-t-cell-lymphoma#diagnosis<\/a> Accessed July 2024.<\/li>\n<li>Walia, Ritika, and Yeung. \u2018An Update on Molecular Biology of Cutaneous T Cell Lymphoma.\u2019 Frontiers in oncology, vol. 9, January 2020, <a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2019.01558\/full\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.3389\/fonc.2019.01558<\/a> Accessed July 2024<\/li>\n<li>Kyowa Kirin. 2020. XLHLink. Available at: <a href=\"https:\/\/jpn01.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fxlhlink.eu%2Findex.html&amp;data=05%7C02%7CChris.Howden%40kyowakirin.com%7C4f8d0ac64ffe49b05a3e08dc8621f826%7C34db9a5d91ba486ebb82d37d2ee1d84c%7C0%7C0%7C638532727790082028%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=OX0FRXyKTjvGSc72flEqysdREoHnzxPyiWqxFOoRvlA%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\">https:\/\/xlhlink.eu\/index.html<\/a> Accessed July 2024.<\/li>\n<li>Dahir, Kathryn, et al. &#8216;Diagnosis and Management of Tumor-Induced Osteomalacia: Perspectives from Clinical Experience.&#8217; Journal of the Endocrine Society, vol. 5, no. 9, June 2021, <a href=\"https:\/\/jpn01.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fdoi.org%2F10.1210%2Fjendso%2Fbvab099&amp;data=05%7C02%7CChris.Howden%40kyowakirin.com%7C4f8d0ac64ffe49b05a3e08dc8621f826%7C34db9a5d91ba486ebb82d37d2ee1d84c%7C0%7C0%7C638532727790087250%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=jGgxfb0eot7mQGd9PUNhDugoe5iLQmAFGSko2j1r3EA%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1210\/jendso\/bvab099<\/a>. Accessed July 2024<\/li>\n<li>Orchard Therapeutics. 2020. Neurometabolic Disorders. Available at: <a href=\"https:\/\/orchard-tx.com\/focus\/#MLD\" target=\"_blank\" rel=\"noopener\">https:\/\/orchard-tx.com\/focus\/#MLD<\/a> Accessed July 2024.<\/li>\n<\/ul>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#5d6164&#8243; custom_margin=&#8221;||||false|false&#8221; top_divider_style=&#8221;curve&#8221; top_divider_color=&#8221;#FFFFFF&#8221; top_divider_height=&#8221;71px&#8221; top_divider_repeat=&#8221;1x&#8221; top_divider_flip=&#8221;vertical&#8221; top_divider_style_tablet=&#8221;&#8221; top_divider_style_phone=&#8221;none&#8221; top_divider_style_last_edited=&#8221;on|desktop&#8221; global_module=&#8221;3417&#8243; saved_tabs=&#8221;all&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;70%&#8221; max_width=&#8221;100%&#8221; custom_margin=&#8221;-50px||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/KKI-Logo-White-PhotoRoom-1-300&#215;86.png&#8221; title_text=&#8221;KKI Logo White-PhotoRoom&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;200px&#8221; width_tablet=&#8221;15%&#8221; width_phone=&#8221;50%&#8221; width_last_edited=&#8221;on|phone&#8221; module_alignment=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_6,1_6,1_6&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;70%&#8221; max_width=&#8221;100%&#8221; custom_padding=&#8221;||27px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_4_text_color=&#8221;#FFFFFF&#8221; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; custom_padding=&#8221;5px|10px|5px|10px|false|false&#8221; border_width_all=&#8221;1px&#8221; border_color_all=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<p style=\"text-align: center;\"><span style=\"color: #ffffff;\"><a href=\"https:\/\/kyowakirininternational.com\/global-reporting\/\" title=\"Report an Adverse Event\" target=\"_blank\" style=\"color: #ffffff;\" rel=\"noopener\">BIJWERKINGEN DIENEN HIER TE WORDEN GEMELD<\/a><\/span><\/p>[\/et_pb_text][et_pb_text content_tablet=&#8221;&#8221; content_phone=&#8221;&#8221; content_last_edited=&#8221;on|phone&#8221; module_class=&#8221;my-popup2&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;||||||||&#8221; text_text_color=&#8221;#E02B20&#8243; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||||false|false&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;-50px||||false|false&#8221; custom_margin_last_edited=&#8221;on|desktop&#8221; custom_padding=&#8221;||||false|false&#8221; text_font_size_tablet=&#8221;&#8221; text_font_size_phone=&#8221;&#8221; text_font_size_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<p style=\"text-align: left;\"><span style=\"color: #ffffff;\"><a href=\"https:\/\/clinicaltrials.gov\/search?term=Kyowa%20Kirin&amp;city=\" target=\"_blank\" rel=\"noopener\" title=\"Clinical Trials\" style=\"color: #ffffff;\">Klik hier om te zoeken naar klinische onderzoeken van Kyowa Kirin<\/a><\/span><\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_6&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;||||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; text_font_size=&#8221;16px&#8221; global_colors_info=&#8221;{}&#8221;]<p><span style=\"color: #ffffff;\"><a href=\"https:\/\/kyowakirininternational.com\/nl-nl\/nieuws-en-informatiebronnen\/#press\" style=\"color: #ffffff;\">Pers en media<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a href=\"https:\/\/kyowakirininternational.com\/nl-nl\/personeel-en-carri\u00e8res\/\" style=\"color: #ffffff;\">Carri\u00e8res<\/a><\/span><\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_6&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; text_font_size=&#8221;16px&#8221; text_text_color_tablet=&#8221;&#8221; text_text_color_phone=&#8221;&#8221; text_text_color_last_edited=&#8221;on|desktop&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;on|desktop&#8221; text_text_color__hover=&#8221;#FFFFFF&#8221;]<span style=\"color: #ffffff;\"><a href=\"https:\/\/kyowakirininternational.com\/global-reporting\/\" target=\"_blank\" style=\"color: #ffffff;\" rel=\"noopener\">Rapportage<\/a><\/span><br \/>\n<span style=\"color: #ffffff;\"><a href=\"https:\/\/kyowakirininternational.com\/nl-nl\/wie-we-zijn\/verantwoordelijkheid\" style=\"color: #ffffff;\">Verantwoordelijkheid<\/a><\/span>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_6&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;70%&#8221; max_width=&#8221;100%&#8221; custom_padding=&#8221;||27px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_4_text_color=&#8221;#FFFFFF&#8221; header_6_text_color=&#8221;#FFFFFF&#8221; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;]<h4><a href=\"https:\/\/kyowakirininternational.com\/nl-nl\/wie-we-zijn\/\">OVER ONS<\/a>\u00a0 |\u00a0 <a href=\"https:\/\/kyowakirininternational.com\/nl-nl\/contact\/\">CONTACT<\/a>\u00a0 |\u00a0 <a href=\"https:\/\/kyowakirininternational.com\/nl-nl\/verklaringen\/\" title=\"Verklaringen \">VERKLARINGEN <\/a>\u00a0 |\u00a0 <a href=\"https:\/\/kyowakirininternational.com\/nl-nl\/verklaringen\/\" title=\"GEBRUIKSVOORWAARDEN\">GEBRUIKSVOORWAARDEN<\/a><\/h4>\n<h4>| <a href=\"https:\/\/kyowakirininternational.com\/nl-nl\/verklaringen\/\" title=\"GEDRAGSCODE VOOR DERDEN \">GEDRAGSCODE VOOR DERDEN <\/a><\/h4>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;70%&#8221; max_width=&#8221;100%&#8221; custom_margin=&#8221;-50px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;]<p><span><\/span><\/p>\n<p><span data-contrast=\"auto\" xml:lang=\"EN-GB\" lang=\"EN-GB\" class=\"TextRun SCXW186711718 BCX8\"><span class=\"NormalTextRun SCXW186711718 BCX8\">Copyright \u00a9 Kyowa Kirin International plc. <\/span><\/span><span data-contrast=\"auto\" xml:lang=\"NL-NL\" lang=\"NL-NL\" class=\"TextRun SCXW186711718 BCX8\"><span class=\"NormalTextRun SCXW186711718 BCX8\">Alle rechten voorbehouden.\u202fDeze website is ontwikkeld en wordt gefinancierd door Kyowa Kirin International <\/span><span class=\"NormalTextRun SCXW186711718 BCX8\">plc<\/span><span class=\"NormalTextRun SCXW186711718 BCX8\">.<\/span><\/span><span class=\"EOP SCXW186711718 BCX8\" data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\" xml:lang=\"NL-NL\" lang=\"NL-NL\" class=\"TextRun SCXW42953415 BCX8\"><span class=\"NormalTextRun SCXW42953415 BCX8\">Kyowa Kirin International <\/span><span class=\"NormalTextRun SCXW42953415 BCX8\">plc<\/span><span class=\"NormalTextRun SCXW42953415 BCX8\"> is een bedrijf dat is geregistreerd in Schotland (bedrijfsregistratienummer SC198780), waarvan het hoofdkantoor is gevestigd te Galabank Business Park, <\/span><span class=\"NormalTextRun SCXW42953415 BCX8\">Galashiels<\/span><span class=\"NormalTextRun SCXW42953415 BCX8\"> TD1 1QH, Verenigd Koninkrijk.<\/span><\/span><\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#5d6164&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;70%&#8221; max_width=&#8221;100%&#8221; custom_margin=&#8221;-100px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<p><span data-teams=\"true\">KKI\/NL\/KKI\/0169 &#8211; April 2025<\/span><\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]\n","protected":false},"excerpt":{"rendered":"<p>As a Japan-based global specialty pharmaceutical company, we are committed to delivering medicines and treatments with life-changing value for people impacted by under-diagnosed and under-served diseases.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":888,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-895","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Under-diagnosticerede og underbetjente sygdomme | Kyowa Kirin<\/title>\n<meta name=\"description\" content=\"Kyowa Kirin: Baner vejen for behandlinger af sj\u00e6ldne sygdomme som CTCL, XLH, MLD og mere. Udforsk innovative l\u00f8sninger for underdiagnosticerede og underbetjente tilstande.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Onze aandachtsgebieden\" \/>\n<meta property=\"og:description\" content=\"Kyowa Kirin: Baner vejen for behandlinger af sj\u00e6ldne sygdomme som CTCL, XLH, MLD og mere. Udforsk innovative l\u00f8sninger for underdiagnosticerede og underbetjente tilstande.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/\" \/>\n<meta property=\"og:site_name\" content=\"Kyowa Kirin International - NL - NL\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-11T11:05:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/Link-to-external-1.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/\",\"url\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/\",\"name\":\"Under-diagnosticerede og underbetjente sygdomme | Kyowa Kirin\",\"isPartOf\":{\"@id\":\"https:\/\/kyowakirininternational.com\/nl-nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/Link-to-external-1.png\",\"datePublished\":\"2024-02-01T13:27:48+00:00\",\"dateModified\":\"2025-06-11T11:05:41+00:00\",\"description\":\"Kyowa Kirin: Baner vejen for behandlinger af sj\u00e6ldne sygdomme som CTCL, XLH, MLD og mere. Udforsk innovative l\u00f8sninger for underdiagnosticerede og underbetjente tilstande.\",\"breadcrumb\":{\"@id\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/#primaryimage\",\"url\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/Link-to-external-1.png\",\"contentUrl\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/Link-to-external-1.png\",\"width\":26,\"height\":28},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kyowakirininternational.com\/nl-nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wat we doen\",\"item\":\"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Onze aandachtsgebieden\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kyowakirininternational.com\/nl-nl\/#website\",\"url\":\"https:\/\/kyowakirininternational.com\/nl-nl\/\",\"name\":\"Kyowa Kirin International - NL - NL\",\"description\":\"A Specialty Pharmaceutical Company\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kyowakirininternational.com\/nl-nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Under-diagnosticerede og underbetjente sygdomme | Kyowa Kirin","description":"Kyowa Kirin: Baner vejen for behandlinger af sj\u00e6ldne sygdomme som CTCL, XLH, MLD og mere. Udforsk innovative l\u00f8sninger for underdiagnosticerede og underbetjente tilstande.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/","og_locale":"en_GB","og_type":"article","og_title":"Onze aandachtsgebieden","og_description":"Kyowa Kirin: Baner vejen for behandlinger af sj\u00e6ldne sygdomme som CTCL, XLH, MLD og mere. Udforsk innovative l\u00f8sninger for underdiagnosticerede og underbetjente tilstande.","og_url":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/","og_site_name":"Kyowa Kirin International - NL - NL","article_modified_time":"2025-06-11T11:05:41+00:00","og_image":[{"url":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/Link-to-external-1.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/","url":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/","name":"Under-diagnosticerede og underbetjente sygdomme | Kyowa Kirin","isPartOf":{"@id":"https:\/\/kyowakirininternational.com\/nl-nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/#primaryimage"},"image":{"@id":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/#primaryimage"},"thumbnailUrl":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/Link-to-external-1.png","datePublished":"2024-02-01T13:27:48+00:00","dateModified":"2025-06-11T11:05:41+00:00","description":"Kyowa Kirin: Baner vejen for behandlinger af sj\u00e6ldne sygdomme som CTCL, XLH, MLD og mere. Udforsk innovative l\u00f8sninger for underdiagnosticerede og underbetjente tilstande.","breadcrumb":{"@id":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/#primaryimage","url":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/Link-to-external-1.png","contentUrl":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-content\/uploads\/sites\/16\/2024\/01\/Link-to-external-1.png","width":26,"height":28},{"@type":"BreadcrumbList","@id":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/onze-aandachtsgebieden\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kyowakirininternational.com\/nl-nl\/"},{"@type":"ListItem","position":2,"name":"Wat we doen","item":"https:\/\/kyowakirininternational.com\/nl-nl\/wat-we-doen\/"},{"@type":"ListItem","position":3,"name":"Onze aandachtsgebieden"}]},{"@type":"WebSite","@id":"https:\/\/kyowakirininternational.com\/nl-nl\/#website","url":"https:\/\/kyowakirininternational.com\/nl-nl\/","name":"Kyowa Kirin International - NL - NL","description":"A Specialty Pharmaceutical Company","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kyowakirininternational.com\/nl-nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-json\/wp\/v2\/pages\/895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-json\/wp\/v2\/comments?post=895"}],"version-history":[{"count":37,"href":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-json\/wp\/v2\/pages\/895\/revisions"}],"predecessor-version":[{"id":3557,"href":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-json\/wp\/v2\/pages\/895\/revisions\/3557"}],"up":[{"embeddable":true,"href":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-json\/wp\/v2\/pages\/888"}],"wp:attachment":[{"href":"https:\/\/kyowakirininternational.com\/nl-nl\/wp-json\/wp\/v2\/media?parent=895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}